On Tuesday, StemCells Inc (NASDAQ:STEM)’s shares inclined 4.35% to $0.460.
StemCells Inc (STEM) a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system diseases and disorders, declared that Health Canada has authorized the Company to expand its Phase II clinical trial for chronic cervical spinal cord injury into Canada. The Pathway Study(TM) is designed to assess the efficacy of the Company’s proprietary HuCNS-SC(R) platform technology (purified human neural stem cells) for the treatment of cervical spinal cord injury with the primary efficacy outcome being the change in motor strength of the various muscle groups in the upper extremities innervated by the cervical spinal cord.
StemCells, Inc., a biopharmaceutical company, researches, develops, and commercializes cell-based therapeutics and related technologies for stem cell-based research and drug discovery and development. It engages in clinical development of its platform technology, HuCNS-SC, a purified human neural stem cells used as a potential treatment for disorders of the central nervous system.
Allison Transmission Holdings Inc (NYSE:ALSN)’s shares dropped -0.07% to $27.74.
Allison Transmission Holdings Inc. (ALSN) declared that it has been working with the U.S. Environmental Protection Agency (EPA) and National Highway Traffic Safety Administration (NHTSA) as they consider revisions to the ‘Phase I’ Model Year 2014-2018 rule regarding fuel efficiency and greenhouse gas emission (GHG) standards for medium and heavy-duty vehicles. The revisions would potentially extend the Phase I program into the middle of the next decade.
Allison is the world’s largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles and is a leader in hybrid-propulsion systems for city buses. Celebrating its centennial in 2015, the company continues to focus on fully understanding and addressing the needs of its customers. Accordingly, Allison has embraced the opportunity to collaborate with EPA and NHTSA to align any regulatory effort with the technological and commercial realities of the tractor and vocational vehicle markets.
Allison Transmission Holdings, Inc., together with its auxiliaries, designs, manufactures, and sells commercial and defense fully-automatic transmissions for medium- and heavy-duty commercial vehicles, and medium- and heavy-tactical U.S. defense vehicles. It offers transmissions for various applications, counting distribution, refuse, construction, fire, and emergency on-highway trucks; school, transit, and hybrid-transit buses; motor homes; energy, mining, and construction off-highway vehicles and equipment; and wheeled and tracked defense vehicles.
At the end of Tuesday ‘s trade, Chicago Bridge & Iron Company N.V. (NYSE:CBI)‘s shares dipped -3.45% to $42.77.
CB&I (CBI) stated the second quarter resulted in strong earnings, improved cash flow and comprising operating performance. Net income for the second quarter was $169.5 million, or $1.55 per diluted share, an enhance of 14 percent from adjusted net income for the comparable period in 2014. Revenues were $3.2 billion, counting a $240 million negative impact attributable to the translation effect of the strong dollar. Net cash offered by operating activities during the second quarter was $95 million. New awards for the second quarter totaled $2.8 billion, and new awards for the first six months totaled $5.9 billion. Backlog remained fairly constant at nearly $29.4 billion, counting an adverse foreign exchange impact of $270 million year to date.
During the quarter, CB&I and its joint venture partners Chiyoda Corporation and Saipem were selected by Anadarko Petroleum Corporation to design and construct process and ancillary infrastructure associated with its LNG development program in Mozambique. CB&I anticipates to book its share of the initial phase of the project in the fourth quarter.
Chicago Bridge & Iron Company N.V. provides conceptual design, technology, engineering, procurement, fabrication, modularization, construction, commissioning, maintenance, program administration, and environmental services worldwide. The companys Engineering, Construction and Maintenance segment offers engineering, procurement, and construction services for energy infrastructure facilities, in addition to comprehensive and integrated maintenance services. Its projects comprise nuclear, fossil, and renewable electric generating plants for the power industry; and upstream and downstream process facilities for the oil and gas industry.
Marsh & McLennan Companies, Inc. (NYSE:MMC), ended its Tuesday ‘s trading session with -3.02% loss, and closed at $52.10.
Marsh & McLennan Agency LLC (MMA), the middle market agency partner of Marsh, recently declared that it has attained Tequesta Insurance Advisors, a leading personal, commercial, and employee benefits insurance provider in Florida. Terms of the transaction were not revealed.
With about $10 million in annual revenues and 50 employees, Tequesta adds additional property/casualty capabilities and personal lines expertise to MMA’ s Florida region. All of Tequesta’s employees are joining MMA and will continue to operate out of the agency’s Tequesta, Florida office.
Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions primarily in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services; and Consulting. The Risk and Insurance Services segment offers risk administration services, such as risk advice, risk transfer, risk control, and mitigation solutions, in addition to insurance, reinsurance broking, catastrophe and financial modeling services, and related advisory services. This segment provides its services for businesses, public entities, insurance companies, associations, professional services organizations, and private clients.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
